Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoki Origuchi

Showing results (91-100 of 227) with videos related to

Pageof 23
Sort By:
Modern Rheumatology|January 18, 2011
In rheumatoid arthritis patients treated with tocilizumab, the rate of clinical disease activity index (CDAI) remission at 24 weeks is superior in those with higher titers of IgM-rheumatoid factor at baselineShin-Ya Kawashiri, Atsushi Kawakami, Naoki Iwamoto, et al.
Modern Rheumatology|June 29, 2010
Successful treatment of chronic lupus myocarditis with prednisolone and mizoribineSatoru Akazawa, Kunihiro Ichinose, Tomoki Origuchi, et al.
Modern Rheumatology|October 6, 2009
Switching to the anti-interleukin-6 receptor antibody tocilizumab in rheumatoid arthritis patients refractory to antitumor necrosis factor biologicsShin-ya Kawashiri, Atsushi Kawakami, Naoki Iwamoto, et al.
International Journal of Rheumatic Diseases|April 11, 2014
Risk factors of adverse events during treatment in elderly patients with rheumatoid arthritis: an observational studyNozomi Iwanaga, Kazuhiko Arima, Kaoru Terada, et al.
Medicine|September 16, 2016
Antineutrophilic cytoplasmic antibody-associated vasculitis with hypocomplementemia has a higher incidence of serious organ damage and a poor prognosisShoichi Fukui, Naoki Iwamoto, Masataka Umeda, et al.
Internal Medicine (Tokyo, Japan)|July 19, 2006
Examination of IgM rheumatoid factor (IgM-RF) and anti-cyclic citrullinated peptide antibody (anti-CCP Ab) in Japanese patients with palindromic rheumatismMami Tamai, Atsushi Kawakami, Nozomi Iwanaga, et al.
Internal Medicine (Tokyo, Japan)|October 22, 2010
Efficacy and safety of mizoribine by one single dose administration for patients with rheumatoid arthritisKunihiro Ichinose, Tomoki Origuchi, Shin-ya Kawashiri, et al.
Modern Rheumatology|November 26, 2010
Contribution of an adenine to guanine single nucleotide polymorphism of the matrix metalloproteinase-13 (MMP-13) -77 promoter region to the production of anticyclic citrullinated peptide antibodies in patients with HLA-DRB1*shared epitope-negative rheumatoid arthritisNaoki Iwamoto, Atsushi Kawakami, Kazuhiko Arima, et al.
Rheumatology (Oxford, England)|May 14, 2010
Regulation of disease susceptibility and mononuclear cell infiltration into the labial salivary glands of Sjögren's syndrome by monocyte chemotactic protein-1Naoki Iwamoto, Atsushi Kawakami, Kazuhiko Arima, et al.
Modern Rheumatology|October 9, 2009
Cutaneous vasculitis induced by TNF inhibitors: a report of three casesKeita Fujikawa, Atsushi Kawakami, Tomayoshi Hayashi, et al.
Pageof 23

Showing results (91-100 of 227) with videos related to

Sort By:
Pageof 23
Modern Rheumatology|January 18, 2011
In rheumatoid arthritis patients treated with tocilizumab, the rate of clinical disease activity index (CDAI) remission at 24 weeks is superior in those with higher titers of IgM-rheumatoid factor at baselineShin-Ya Kawashiri, Atsushi Kawakami, Naoki Iwamoto, et al.
Modern Rheumatology|June 29, 2010
Successful treatment of chronic lupus myocarditis with prednisolone and mizoribineSatoru Akazawa, Kunihiro Ichinose, Tomoki Origuchi, et al.
Modern Rheumatology|October 6, 2009
Switching to the anti-interleukin-6 receptor antibody tocilizumab in rheumatoid arthritis patients refractory to antitumor necrosis factor biologicsShin-ya Kawashiri, Atsushi Kawakami, Naoki Iwamoto, et al.
International Journal of Rheumatic Diseases|April 11, 2014
Risk factors of adverse events during treatment in elderly patients with rheumatoid arthritis: an observational studyNozomi Iwanaga, Kazuhiko Arima, Kaoru Terada, et al.
Medicine|September 16, 2016
Antineutrophilic cytoplasmic antibody-associated vasculitis with hypocomplementemia has a higher incidence of serious organ damage and a poor prognosisShoichi Fukui, Naoki Iwamoto, Masataka Umeda, et al.
Internal Medicine (Tokyo, Japan)|July 19, 2006
Examination of IgM rheumatoid factor (IgM-RF) and anti-cyclic citrullinated peptide antibody (anti-CCP Ab) in Japanese patients with palindromic rheumatismMami Tamai, Atsushi Kawakami, Nozomi Iwanaga, et al.
Internal Medicine (Tokyo, Japan)|October 22, 2010
Efficacy and safety of mizoribine by one single dose administration for patients with rheumatoid arthritisKunihiro Ichinose, Tomoki Origuchi, Shin-ya Kawashiri, et al.
Modern Rheumatology|November 26, 2010
Contribution of an adenine to guanine single nucleotide polymorphism of the matrix metalloproteinase-13 (MMP-13) -77 promoter region to the production of anticyclic citrullinated peptide antibodies in patients with HLA-DRB1*shared epitope-negative rheumatoid arthritisNaoki Iwamoto, Atsushi Kawakami, Kazuhiko Arima, et al.
Rheumatology (Oxford, England)|May 14, 2010
Regulation of disease susceptibility and mononuclear cell infiltration into the labial salivary glands of Sjögren's syndrome by monocyte chemotactic protein-1Naoki Iwamoto, Atsushi Kawakami, Kazuhiko Arima, et al.
Modern Rheumatology|October 9, 2009
Cutaneous vasculitis induced by TNF inhibitors: a report of three casesKeita Fujikawa, Atsushi Kawakami, Tomayoshi Hayashi, et al.
Pageof 23